Clinical Trial Update: Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use Disorder [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on add-on low-dose dextromethorphan and memantine for stimulants use disorder (Phase 1/Phase 2), completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stimulants Use Disorder

Drugs mentioned

• Dextromethorphan (dextromethorphan)
• Memantine (memantine)

Snippet

Sponsor: Tzu-Yun Wang | Conditions: Stimulants Use Disorder | Phase 1, Phase 2 | Status: COMPLETED